Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting, 25803 [2017-11494]

Download as PDF Federal Register / Vol. 82, No. 106 / Monday, June 5, 2017 / Notices (12 CFR 225.28) or that the Board has determined by Order to be closely related to banking and permissible for bank holding companies. Unless otherwise noted, these activities will be conducted throughout the United States. Each notice is available for inspection at the Federal Reserve Bank indicated. The notice also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the question whether the proposal complies with the standards of section 4 of the BHC Act. Unless otherwise noted, comments regarding the applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than June 19, 2017. A. Federal Reserve Bank of St. Louis (David L. Hubbard, Senior Manager) P.O. Box 442, St. Louis, Missouri 63166–2034. Comments can also be sent electronically to Comments .applications@stls.frb.org: 1. Paramount Financial Group, LLC, St. Louis, Missouri; to acquire 100 percent of the voting shares of Paramount Bond & Mortgage Co., Inc., St. Louis, Missouri, and thereby engage in mortgage activities pursuant to section 225.28(b)(1) of Regulation Y. Board of Governors of the Federal Reserve System, May 31, 2017. Yao-Chin Chao, Assistant Secretary of the Board. [FR Doc. 2017–11527 Filed 6–2–17; 8:45 am] BILLING CODE 6210–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on June 23, 2017. The subject of the meeting will be ‘‘Measurement Science and Glycemic Control.’’ The meeting is open to the public. DATES: The meeting will be held on June 23, 2017; from 8:30 a.m. to 4:30 p.m. Individuals wanting to present oral comments must notify the contact person at least 10 days before the meeting date. ADDRESSES: The meeting will be held in the Democracy 2 Building at 6707 Democracy Blvd., Bethesda, MD, in Conference Room 7050. FOR FURTHER INFORMATION CONTACT: For further information concerning this asabaliauskas on DSKBBXCHB2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:31 Jun 02, 2017 Jkt 241001 25803 meeting, see the DMICC Web site, www.diabetescommittee.gov, or contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes Mellitus Interagency Coordinating Committee, National Institute of Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 31A, Room 9A19, MSC 2560, Bethesda, MD 20892– 2560, telephone: 301–496–6623; FAX: 301–480–6741; email: dmicc@ mail.nih.gov. Dated: May 23, 2017. B. Tibor Roberts, Executive Secretary, DMICC, Office of Scientific Program and Policy Analysis, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. The DMICC, chaired by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) comprising members of the Department of Health and Human Services and other federal agencies that support diabetes-related activities, facilitates cooperation, communication, and collaboration on diabetes among government entities. DMICC meetings, held several times a year, provide an opportunity for Committee members to learn about and discuss current and future diabetes programs in DMICC member organizations and to identify opportunities for collaboration. The June 23, 2017 DMICC meeting will focus on Measurement Science and Glycemic Control. Any member of the public interested in presenting oral comments to the Committee should notify the contact person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives or organizations should submit a letter of intent, a brief description of the organization represented, and a written copy of their oral presentation in advance of the meeting. Only one representative of an organization will be allowed to present; oral comments and presentations will be limited to a maximum of 5 minutes. Printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the Committee by forwarding their statement to the contact person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Because of time constraints for the meeting, oral comments will be allowed on a first-come, first-serve basis. Members of the public who would like to receive email notification about future DMICC meetings should register for the listserv available on the DMICC Web site, www.diabetescommittee.gov. National Institutes of Health SUPPLEMENTARY INFORMATION: PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 [FR Doc. 2017–11494 Filed 6–2–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; LTCDS Contract Review. Date: June 27, 2017. Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Michele L. Barnard, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7353, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, (301) 594–8898, barnardm@extra.niddk.nih.gov. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; SBIR Phase II Exploratory Clinical Trials. Date: June 30, 2017. Time: 12:00 p.m. to 1:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Thomas A. Tatham, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 7021, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–3993, tathamt@mail.nih.gov. E:\FR\FM\05JNN1.SGM 05JNN1

Agencies

[Federal Register Volume 82, Number 106 (Monday, June 5, 2017)]
[Notices]
[Page 25803]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-11494]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Diabetes Mellitus Interagency Coordinating Committee 
Meeting

SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee 
(DMICC) will hold a meeting on June 23, 2017. The subject of the 
meeting will be ``Measurement Science and Glycemic Control.'' The 
meeting is open to the public.

DATES: The meeting will be held on June 23, 2017; from 8:30 a.m. to 
4:30 p.m. Individuals wanting to present oral comments must notify the 
contact person at least 10 days before the meeting date.

ADDRESSES: The meeting will be held in the Democracy 2 Building at 6707 
Democracy Blvd., Bethesda, MD, in Conference Room 7050.

FOR FURTHER INFORMATION CONTACT: For further information concerning 
this meeting, see the DMICC Web site, www.diabetescommittee.gov, or 
contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes 
Mellitus Interagency Coordinating Committee, National Institute of 
Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building 
31A, Room 9A19, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-496-
6623; FAX: 301-480-6741; email: dmicc@mail.nih.gov.

SUPPLEMENTARY INFORMATION: The DMICC, chaired by the National Institute 
of Diabetes and Digestive and Kidney Diseases (NIDDK) comprising 
members of the Department of Health and Human Services and other 
federal agencies that support diabetes-related activities, facilitates 
cooperation, communication, and collaboration on diabetes among 
government entities. DMICC meetings, held several times a year, provide 
an opportunity for Committee members to learn about and discuss current 
and future diabetes programs in DMICC member organizations and to 
identify opportunities for collaboration. The June 23, 2017 DMICC 
meeting will focus on Measurement Science and Glycemic Control.
    Any member of the public interested in presenting oral comments to 
the Committee should notify the contact person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives or organizations should submit a letter of intent, a 
brief description of the organization represented, and a written copy 
of their oral presentation in advance of the meeting. Only one 
representative of an organization will be allowed to present; oral 
comments and presentations will be limited to a maximum of 5 minutes. 
Printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
Committee by forwarding their statement to the contact person listed on 
this notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person. Because of time constraints for the meeting, 
oral comments will be allowed on a first-come, first-serve basis.
    Members of the public who would like to receive email notification 
about future DMICC meetings should register for the listserv available 
on the DMICC Web site, www.diabetescommittee.gov.

    Dated: May 23, 2017.
B. Tibor Roberts,
Executive Secretary, DMICC, Office of Scientific Program and Policy 
Analysis, National Institute of Diabetes and Digestive and Kidney 
Diseases, National Institutes of Health.
[FR Doc. 2017-11494 Filed 6-2-17; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.